Stock 6D81 DUPONT DE NEMOURS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings DuPont de Nemours, Inc. Xetra

Equities

6D81

US26614N1028

Market Closed - Xetra
Other stock markets
 11:35:38 2024-06-20 EDT 		5-day change 1st Jan Change
74.86 EUR -0.13% Intraday chart for DuPont de Nemours, Inc. +0.86% +7.87%
06-13 DuPont Launches New Tedlar® Frontsheet Offerings At 2024 Snec Pv Power Expo CI
06-07 Declaration of Voting Results by DuPont de Nemours, Inc CI

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
  • The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
  • Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • The firm trades with high earnings multiples: 30.45 times its 2024 earnings per share.
  • The company's enterprise value to sales, at 3.16 times its current sales, is high.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Diversified Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
DUPONT DE NEMOURS, INC. Stock DuPont de Nemours, Inc.
+7.87% 33.75B -
SHIN-ETSU CHEMICAL CO., LTD. Stock Shin-Etsu Chemical Co., Ltd.
+4.51% 77.12B
B
BASF SE Stock BASF SE
-6.64% 43.09B
A-
PIDILITE INDUSTRIES LIMITED Stock Pidilite Industries Limited
+15.37% 19.01B
B
EASTMAN CHEMICAL COMPANY Stock Eastman Chemical Company
+9.20% 11.64B
A-
SYENSQO SA/NV Stock Syensqo SA/NV
-4.85% 9.97B -
ASAHI KASEI CORPORATION Stock Asahi Kasei Corporation
-5.91% 8.8B
A-
SRF LIMITED Stock SRF Limited
+0.78% 8.59B
C-
MITSUBISHI CHEMICAL GROUP CORPORATION Stock Mitsubishi Chemical Group Corporation
-1.54% 7.54B
B
SAHARA INTERNATIONAL PETROCHEMICAL COMPANY Stock Sahara International Petrochemical Company
-13.07% 5.64B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. DD Stock
  4. 6D81 Stock
  5. Ratings DuPont de Nemours, Inc.